Healthcare Business Investment Opportunities in Thailand

- Singapore registered company operating in Thailand. - Company specializes in offering in-house developed healthcare portals for B2B and B2C customers. - We have been operational for a few months as a result, our recent sales have grown. - Have over 12,000 B2C clients and around 33 B2B clients. - Revenue is equally split between B2B and B2C sectors. - Our customers are hospitals, telehealthcare providers, clinics, and direct patients. - Business has logistics and clinical licenses. - Company already has an MOU with a company to expand in Singapore. - Planning to provide IoT solutions to hospitals. - Company has no liability and has 18 shareholders.

- Our company developing and market potential pharmaceutical medicines that have no side effects. - The business has invested heavily in the research and development of anti-viral drugs. - Today, we have finished R&D and are ready to start production of a new drug that can help to prevent and treat many diseases including COVID-19. - The investment will be utilized to commence production and fulfil purchase orders from around the world.

We are an innovative company specialized in silicone development for healthcare and pharmaceutical area, established in 2009. We have been selling and exporting to many countries in Asia with our own patents and trade marks. The sales growing well each year so, when the sales increase the investment for funding support are needed. The reason for the loan is to support cash flow and stock inventory. Major products such as silicone gel for scar reduction, Asian formula, and silicone gel sheet for scars. Kelosil silicone gel plus CBD, we are the only one who can combine CBD (cannabidiol into silicone gel with transparent texture, which will a new evolution of silicone gel for wound healing and scar reductuion products. The new invention for cannabis (CBD) product development, we are brand owner of CBD products such as CBD cream, CBD drinks, Estimate Sales (year sales) 2022 = 44,000 USD. 2023 = USD 55,000. 2024 = USD 100,000. 2025 = USD 150,000. 2026 = USD 300,000.

- We plan to cultivate cannabis for medical purpose. We are yet to register our company. - Soon the company will have the ability to vegetate up to 1,500 plants and flowers concurrently. - We will grow up to 4 different strains of marijuana and will be able to grow from seedling to finished product. - We will dry and process all cannabis into labelled/inventoried vacuum-sealed bags before delivery. - The company will distribute products through wholesale transactions to qualified, licensed marijuana establishments. - From a total investment of $250 thousand, company is expected to generate nearly $660 thousand in gross revenues with a pre-tax income of nearly $1.5 million in year 3, its first full year of operations. - Revenue is expected to grow to nearly $3 million in year 4 and $5.9 million in year 5. - Promoter is based in the Philippines and the business will be operational in Thailand. - Image uploaded in the profile is a stock photo.

- We are a startup that will manufacture light therapy devices for personal use. - This technology was previously only available to athletes and wealthy patients but we have reinvented it in order to make it accessible as a premium home use medical device. - Product is used to reduce pain, repair cell tissue, revive circulation and reduce inflammation. - Our management team consists of multiple experts from numerous fields such as supply chain management, light technology and light therapy. - Company's physical assets include office equipment and setup.